NEO   $16.305  -1.00% Market Closed After Close 16.28 -0.15%

Neogenomics Inc
Total Cash 387.86M
totalCashPerShare 3.026
EBITDA -14.24M
Total Debt 606.52M
quickRatio 1.848
currentRatio 2.015
Total Revenue 628.25M
debtToEquity 66.222
Revenue/Share 4.985
ROA -0.03261
ROE -0.083909996
grossProfits
freeCashflow -4.23M
operatingCashflow 264.00K
earningsGrowth
revenueGrowth 0.12
grossMargins 0.42636
ebitdaMargins -0.02266
operatingMargins -0.12399
profitMargins -0.12502
enterpriseValue 2.32B
forwardPE 86.31579
floatShares 126.41M
sharesOutstanding 128.16M
sharesShort 5.14M
sharesShortPriorMonth 4.88M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.01%
Short Ratio help_outline 6.66%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 7.164
Price To Book help_outline 2.29
earningsQuarterlyGrowth
netIncomeToCommon -78.55M
trailingEps -0.62%
forwardEps 0.19%
enterpriseToEbitda -162.99
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.01 3Q 2024
institutionsCount 365
lastUpdated Sept. 16, 2024, 11:59 a.m.